These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7616358)

  • 1. Expression of the ret proto-oncogene in phaeochromocytoma. An in situ hybridization and northern blot study.
    Matias-Guiu X; Colomer A; Mato E; Cuatrecasas M; Komminoth P; Prat J; Wolfe H
    J Pathol; 1995 May; 176(1):63-8. PubMed ID: 7616358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL.
    Woodward ER; Eng C; McMahon R; Voutilainen R; Affara NA; Ponder BA; Maher ER
    Hum Mol Genet; 1997 Jul; 6(7):1051-6. PubMed ID: 9215674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the ret proto-oncogene in human medullary thyroid carcinomas and pheochromocytomas of MEN 2A.
    Miya A; Yamamoto M; Morimoto H; Tanaka N; Shin E; Karakawa K; Toyoshima K; Ishizaka Y; Mori T; Takai S
    Henry Ford Hosp Med J; 1992; 40(3-4):215-9. PubMed ID: 1362408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RET proto-oncogene in sporadic pheochromocytomas.
    Takaya K; Yoshimasa T; Arai H; Tamura N; Miyamoto Y; Itoh H; Nakao K
    Intern Med; 1996 Jun; 35(6):449-52. PubMed ID: 8835594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.
    Eng C; Smith DP; Mulligan LM; Nagai MA; Healey CS; Ponder MA; Gardner E; Scheumann GF; Jackson CE; Tunnacliffe A
    Hum Mol Genet; 1994 Feb; 3(2):237-41. PubMed ID: 7911697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas.
    Santoro M; Rosati R; Grieco M; Berlingieri MT; D'Amato GL; de Franciscis V; Fusco A
    Oncogene; 1990 Oct; 5(10):1595-8. PubMed ID: 1701232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma.
    Eng C; Foster KA; Healey CS; Houghton C; Gayther SA; Mulligan LM; Ponder BA
    Br J Cancer; 1996 Aug; 74(3):339-41. PubMed ID: 8695346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2.
    Pausova Z; Soliman E; Amizuka N; Janicic N; Konrad EM; Arnold A; Goltzman D; Hendy GN
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2711-8. PubMed ID: 8675600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent RET protooncogene mutations in multiple endocrine neoplasia type 2A.
    Quadro L; Panariello L; Salvatore D; Carlomagno F; Del Prete M; Nunziata V; Colantuoni V; Di Giovanni G; Brandi ML; Mannelli M
    J Clin Endocrinol Metab; 1994 Aug; 79(2):590-4. PubMed ID: 7913936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of RET proto-oncogene point mutations in malignant and benign, sporadic phaeochromocytomas.
    van der Harst E; de Krijger RR; Bruining HA; Lamberts SW; Bonjer HJ; Dinjes WN; Proye C; Koper JW; Bosman FT; Roth J; Heitz PU; Komminoth P
    Int J Cancer; 1998 Oct; 79(5):537-40. PubMed ID: 9761126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RET mutation screening in sporadic pheochromocytoma.
    Arnold A
    J Clin Endocrinol Metab; 1996 Jan; 81(1):430. PubMed ID: 8550789
    [No Abstract]   [Full Text] [Related]  

  • 13. The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects.
    Beldjord C; Desclaux-Arramond F; Raffin-Sanson M; Corvol JC; De Keyzer Y; Luton JP; Plouin PF; Bertagna X
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2063-8. PubMed ID: 7608256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
    Sansó G; Domené HM; Iorcansky S; Barontini M
    Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of Ret activation by a mutation at aspartic acid 631 identified in sporadic pheochromocytoma.
    Asai N; Iwashita T; Murakami H; Takanari H; Ohmori K; Ichihara M; Takahashi M
    Biochem Biophys Res Commun; 1999 Feb; 255(3):587-90. PubMed ID: 10049754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2.
    Ponder BA
    Cancer Surv; 1995; 25():195-205. PubMed ID: 8718519
    [No Abstract]   [Full Text] [Related]  

  • 17. RET proto-oncogene mutations and rearrangements in endocrine diseases.
    Lloyd RV
    Am J Pathol; 1995 Dec; 147(6):1539-44. PubMed ID: 7495277
    [No Abstract]   [Full Text] [Related]  

  • 18. Alterations of RET oncogene in human adrenal tumors.
    Lin SR; Yang YC; Tsai JH; Hsu CH
    Jpn J Cancer Res; 1998 Jun; 89(6):634-40. PubMed ID: 9703361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duplication of the mutant RET allele in trisomy 10 or loss of the wild-type allele in multiple endocrine neoplasia type 2-associated pheochromocytomas.
    Huang SC; Koch CA; Vortmeyer AO; Pack SD; Lichtenauer UD; Mannan P; Lubensky IA; Chrousos GP; Gagel RF; Pacak K; Zhuang Z
    Cancer Res; 2000 Nov; 60(22):6223-6. PubMed ID: 11103773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma.
    Crossey PA; Eng C; Ginalska-Malinowska M; Lennard TW; Wheeler DC; Ponder BA; Maher ER
    J Med Genet; 1995 Nov; 32(11):885-6. PubMed ID: 8592333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.